Selected research
Industry Research
Alpha-1-Antitrypsin Antibody Industry Research Report 2026
Market perspective
The global Alpha-1-Antitrypsin Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Alpha-1-Antitrypsin Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Alpha-1-Antitrypsin Antibody market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Alpha-1-Antitrypsin Antibody market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Alpha-1-Antitrypsin Antibody include Abcam, Abnova, Boster Biological Technology, Creative Biolabs, Creative Diagnostics, G Biosciences, LSBio, NSJ Bioreagents and Santa Cruz Biotechnology, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Alpha-1-Antitrypsin Antibody market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Alpha-1-Antitrypsin Antibody.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Alpha-1-Antitrypsin Antibody Market by Company
Abcam
Abnova
Boster Biological Technology
Creative Biolabs
Creative Diagnostics
G Biosciences
LSBio
NSJ Bioreagents
Santa Cruz Biotechnology
Signalway Antibody LLC
United States Biological
Merck
Thermo Fisher Scientific
Alpha-1-Antitrypsin Antibody Segment by Type
Polyclonal
Monoclonal
Alpha-1-Antitrypsin Antibody Segment by Application
Immunohistochemistry Frozen
Enzyme Linked Immunosorbent Assay
Western Blot
Others
Alpha-1-Antitrypsin Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha-1-Antitrypsin Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alpha-1-Antitrypsin Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha-1-Antitrypsin Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Alpha-1-Antitrypsin Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunohistochemistry Frozen
- Enzyme Linked Immunosorbent Assay
- Western Blot
- Others
Companies covered
- Abcam
- Abnova
- Boster Biological Technology
- Creative Biolabs
- Creative Diagnostics
- G Biosciences
- LSBio
- NSJ Bioreagents
- Santa Cruz Biotechnology
- Signalway Antibody LLC
- United States Biological
- Merck
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Alpha-1-Antitrypsin Antibody by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Polyclonal
- 2.2.3 Monoclonal
- 2.3 Alpha-1-Antitrypsin Antibody by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Immunohistochemistry Frozen
- 2.3.3 Enzyme Linked Immunosorbent Assay
- 2.3.4 Western Blot
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Alpha-1-Antitrypsin Antibody Breakdown Data by Type
- 3.1 Global Alpha-1-Antitrypsin Antibody Historic Market Size by Type (2021-2026)
- 3.2 Global Alpha-1-Antitrypsin Antibody Forecasted Market Size by Type (2027-2032)
4 Alpha-1-Antitrypsin Antibody Breakdown Data by Application
- 4.1 Global Alpha-1-Antitrypsin Antibody Historic Market Size by Application (2021-2026)
- 4.2 Global Alpha-1-Antitrypsin Antibody Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Alpha-1-Antitrypsin Antibody Market Perspective (2021-2032)
- 5.2 Global Alpha-1-Antitrypsin Antibody Growth Trends by Region
- 5.2.1 Global Alpha-1-Antitrypsin Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Alpha-1-Antitrypsin Antibody Historic Market Size by Region (2021-2026)
- 5.2.3 Alpha-1-Antitrypsin Antibody Forecasted Market Size by Region (2027-2032)
- 5.3 Alpha-1-Antitrypsin Antibody Market Dynamics
- 5.3.1 Alpha-1-Antitrypsin Antibody Industry Trends
- 5.3.2 Alpha-1-Antitrypsin Antibody Market Drivers
- 5.3.3 Alpha-1-Antitrypsin Antibody Market Challenges
- 5.3.4 Alpha-1-Antitrypsin Antibody Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Alpha-1-Antitrypsin Antibody Players by Revenue
- 6.1.1 Global Top Alpha-1-Antitrypsin Antibody Players by Revenue (2021-2026)
- 6.1.2 Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Players (2021-2026)
- 6.2 Global Alpha-1-Antitrypsin Antibody Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Alpha-1-Antitrypsin Antibody Head Office and Area Served
- 6.4 Global Alpha-1-Antitrypsin Antibody Players, Product Type & Application
- 6.5 Global Alpha-1-Antitrypsin Antibody Manufacturers Established Date
- 6.6 Global Alpha-1-Antitrypsin Antibody Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Alpha-1-Antitrypsin Antibody Market Size (2021-2032)
- 7.2 North America Alpha-1-Antitrypsin Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Alpha-1-Antitrypsin Antibody Market Size by Country (2021-2026)
- 7.4 North America Alpha-1-Antitrypsin Antibody Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Alpha-1-Antitrypsin Antibody Market Size (2021-2032)
- 8.2 Europe Alpha-1-Antitrypsin Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Alpha-1-Antitrypsin Antibody Market Size by Country (2021-2026)
- 8.4 Europe Alpha-1-Antitrypsin Antibody Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Alpha-1-Antitrypsin Antibody Market Size (2021-2032)
- 9.2 Asia-Pacific Alpha-1-Antitrypsin Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Alpha-1-Antitrypsin Antibody Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Alpha-1-Antitrypsin Antibody Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Alpha-1-Antitrypsin Antibody Market Size (2021-2032)
- 10.2 South America Alpha-1-Antitrypsin Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Alpha-1-Antitrypsin Antibody Market Size by Country (2021-2026)
- 10.4 South America Alpha-1-Antitrypsin Antibody Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Alpha-1-Antitrypsin Antibody Market Size (2021-2032)
- 11.2 Middle East & Africa Alpha-1-Antitrypsin Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Alpha-1-Antitrypsin Antibody Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Alpha-1-Antitrypsin Antibody Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abcam
- 12.1.1 Abcam Company Information
- 12.1.2 Abcam Business Overview
- 12.1.3 Abcam Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.1.4 Abcam Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.1.5 Abcam Recent Developments
- 12.2 Abnova
- 12.2.1 Abnova Company Information
- 12.2.2 Abnova Business Overview
- 12.2.3 Abnova Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.2.4 Abnova Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.2.5 Abnova Recent Developments
- 12.3 Boster Biological Technology
- 12.3.1 Boster Biological Technology Company Information
- 12.3.2 Boster Biological Technology Business Overview
- 12.3.3 Boster Biological Technology Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.3.4 Boster Biological Technology Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.3.5 Boster Biological Technology Recent Developments
- 12.4 Creative Biolabs
- 12.4.1 Creative Biolabs Company Information
- 12.4.2 Creative Biolabs Business Overview
- 12.4.3 Creative Biolabs Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.4.4 Creative Biolabs Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.4.5 Creative Biolabs Recent Developments
- 12.5 Creative Diagnostics
- 12.5.1 Creative Diagnostics Company Information
- 12.5.2 Creative Diagnostics Business Overview
- 12.5.3 Creative Diagnostics Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.5.4 Creative Diagnostics Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.5.5 Creative Diagnostics Recent Developments
- 12.6 G Biosciences
- 12.6.1 G Biosciences Company Information
- 12.6.2 G Biosciences Business Overview
- 12.6.3 G Biosciences Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.6.4 G Biosciences Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.6.5 G Biosciences Recent Developments
- 12.7 LSBio
- 12.7.1 LSBio Company Information
- 12.7.2 LSBio Business Overview
- 12.7.3 LSBio Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.7.4 LSBio Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.7.5 LSBio Recent Developments
- 12.8 NSJ Bioreagents
- 12.8.1 NSJ Bioreagents Company Information
- 12.8.2 NSJ Bioreagents Business Overview
- 12.8.3 NSJ Bioreagents Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.8.4 NSJ Bioreagents Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.8.5 NSJ Bioreagents Recent Developments
- 12.9 Santa Cruz Biotechnology
- 12.9.1 Santa Cruz Biotechnology Company Information
- 12.9.2 Santa Cruz Biotechnology Business Overview
- 12.9.3 Santa Cruz Biotechnology Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.9.4 Santa Cruz Biotechnology Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.9.5 Santa Cruz Biotechnology Recent Developments
- 12.10 Signalway Antibody LLC
- 12.10.1 Signalway Antibody LLC Company Information
- 12.10.2 Signalway Antibody LLC Business Overview
- 12.10.3 Signalway Antibody LLC Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.10.4 Signalway Antibody LLC Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.10.5 Signalway Antibody LLC Recent Developments
- 12.11 United States Biological
- 12.11.1 United States Biological Company Information
- 12.11.2 United States Biological Business Overview
- 12.11.3 United States Biological Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.11.4 United States Biological Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.11.5 United States Biological Recent Developments
- 12.12 Merck
- 12.12.1 Merck Company Information
- 12.12.2 Merck Business Overview
- 12.12.3 Merck Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.12.4 Merck Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.12.5 Merck Recent Developments
- 12.13 Thermo Fisher Scientific
- 12.13.1 Thermo Fisher Scientific Company Information
- 12.13.2 Thermo Fisher Scientific Business Overview
- 12.13.3 Thermo Fisher Scientific Revenue in Alpha-1-Antitrypsin Antibody Business (2021-2026)
- 12.13.4 Thermo Fisher Scientific Alpha-1-Antitrypsin Antibody Product Portfolio
- 12.13.5 Thermo Fisher Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst